BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today issued their quarterly report containing Leqembi sales for the fourth quarter 2024 (third quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback